?Promestriene (CAS 39219-28-8)?
?? ?Product Overview?
Promestriene, a synthetic steroidal estrogen derivative with the molecular formula ?C22H32O2? and molecular weight ?328.49?, is widely used in pharmaceutical and biochemical research. It acts as a local estrogenic agent to treat vaginal atrophy, promote mucosal repair, and support wound healing in gynecological applications. Its low systemic absorption minimizes hormonal side effects, making it ideal for targeted therapies.

?? ?Key Advantages?
? ?High Purity?
HPLC-certified purity ≥99.5%, ensuring reliability for pharmaceutical formulations.

?? ?Stability?
Stable under ?2-8°C? in dry conditions with a ?36-month shelf life?.

??? ?Safety Compliance?
Meets ?GMP/ISO standards? with heavy metal content ≤10ppm.

?? ?Applications?

• ?Pharmaceuticals?

  : Core ingredient in topical estrogen therapies for vaginal atrophy and hormone replacement.

• ?Research?

  : Studies hormone-related biochemical mechanisms and drug interactions.

• ?Synthesis?

  : Intermediate for anti-estrogen drugs like Clomiphene.

?? ?Quality Certifications?

• Complies with ?USP/EP testing protocols?.

• Batch-specific Certificates of Analysis (COA) available.

?? ?Market Trends?
The global hormone therapy market is projected to grow at ?6.8% CAGR (2023-2030)?, driven by rising demand for localized estrogen treatments. Promestriene’s role in women’s health positions it as a high-potential API.